The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

The German inflation brain teaser

Thu, 09th Feb 2023 10:57

STOXX 600 up 0.8%

*

German inflation dips

*

Takeover talk boosts StanChart

*

U.S. stock futures rise

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

THE GERMAN INFLATION BRAIN TEASER (1051 GMT)

Germany's lower-than-expected headline inflation offers some relief to the fixed-income market, but analysts are having trouble assessing the outlook.

"The methodological uncertainty around the inflation figures for December 2022 and January and February 2023 is much higher than usual," says Salomon Fiedler, an economist at Berenberg.

"The government is intervening heavily in household energy markets, but it is, a priori, unclear to which extent this will show up in the data collected by the statisticians," he adds.

German consumer prices rose by 9.2% in January.

"The energy price cap will come into effect as of 1 March but will be paid retroactively," ING analysts note.

"According to Bundesbank estimates, energy price caps and cheap public transportation tickets will lower average German inflation by 1.5 percentage points this year," they say.

And there is more. "Negative base effects from last year's energy relief package for the summer months should automatically push up headline inflation between June and August," they add.

Bottom line, according to Citi analysts, "today's data does not yet necessarily imply that core or underlying inflation is on a lower path, nor that the surprise is persistent."

STOXX: ACTION-PACKED START (0936 GMT)

There was no lack of action at the open today in Europe with corporate dealmaking, earnings reports and a softer-than-expected inflation print in Germany sparking broad-based gains and pushing indices to fresh highs.

Well-received numbers from drugmaker AstraZeneca drove the FTSE 100 to a new lifetime peak, up 1.1%.

Also helping was a spike of over 10% in StanChart after a Bloomberg reported that First Abu Dhabi Bank is still considering a potential offer for the UK bank. On the downside, Entain slumped 10% after U.S-based MGM Resorts said it was no longer from pursuing an offer for the gambling firm.

The STOXX 600 meanwhile rose 0.8% to a fresh 10-month high, although gains were capped by some disappointing updates from Delivery Hero and GN Store Nord.

In banks, Credit Suisse saw its worst annual loss since 2008, sending its shares down 6%. Credit Agricole posted strong numbers, pushing its shares higher.

EUROPEAN SHARES SET FOR POSITIVE START (0737 GMT)

Shares in Europe are expected to rise this morning, tracking a bounce in U.S. futures and following data showing German inflation rose by a less than anticipated 9.2% in January, which could ease pressure on the ECB to keep raising rates.

EuroSTOXX 50 and FTSE futures are up 0.6% and 0.3%, respectively, and S&P 500 contracts added 0.4%.

On another heavy day in Europe's earnings season, eyes are on Credit Suisse. The Swiss bank posted its worst annual loss since 2008 and warned that a further "substantial" loss would come this year. Its shares were down 4.7% in the premarket.

On a more upbeat note, Credit Agricole posted a higher-than-expected profit, driven by lower loan provisions and a strong performance at its investment banking division.

In the UK, Unilever reported quarterly underlying sales growth above expectations and AstraZeneca posted fourth-quarter revenue just shy of analyst estimates.

BAR-DUH (0656 GMT)

Surely the most fun story today, unless you are an Alphabet shareholder, is Google's new Bard AI flunking a question on the James Webb telescope. And it was an own goal given the error was in a Twitter video put out by Google itself, ouch.

Alphabet's shares sank almost 8%, wiping a cool $100 billion off its market cap, and dragging all of Wall Street down. But it did produce one of our best headlines of the session: "Alphabet's Bard apparently no Shakespeare." Eat your heart out AI.

There's been scant fun in Asian markets with everyone already stressing about next week's U.S. CPI report and what that will mean for the likely peak of Fed rates.

In Europe, the Riksbank meeting will be interesting if only because both the governor and deputy are new to the roles, so there's no knowing if the central bank's reaction function has changed.

Markets are priced for a half-point hike to 3.0%, in part to match the ECB and stop the SEK from weakening yet further. It's been falling steadily on the euro since late 2021, making it all the harder to fight inflation.

Assuming it goes 50 bps, and not 75 bps, the focus will be on the outlook for further tightening. Markets are fully priced for a move to 3.25%, with 3.5% an even bet.

If this week's hikes by central banks in India and Australia are anything to go by, the risk is for a hawkish outcome in Sweden.

Further out, JPMorgan analysts note household debt in Sweden is twice the EU average making it tough for the Riksbank to keep a half-point spread over ECB rates.

"Monetary policy in Sweden is clearly more restrictive than in the Euro-area," they say. "If the ECB therefore ends up with a 3.25% terminal rate (our forecast), we think the Riksbank will not be able to follow suit and take the policy rate to 3.75%."

There are blessedly no Fed speakers today, but Bank of England Governor Andrew Bailey will be grilled by lawmakers - among the few people in the country not on strike - about its recent rate rise and the ever-growing risk of recession.

The BoE line has been they may have done enough, but are not sure and are ready to do more if needed.

Key developments that could influence markets on Thursday:

- Riksbank rate decision and Feb monetary policy report due at 0830 GMT. Governor Erik Thedéen and Jesper Hansson, head of the Monetary Policy Department hold presser at 1000 GMT

- BoE Governor Bailey speaks to lawmakers at 0945 GMT

- The delayed German Jan CPI is due at 0700 GMT and could cause fireworks if stronger than the forecast 8.9% y/y

More News
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.